Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes
80+
1 other identifier
interventional
200
1 country
1
Brief Summary
A multicenter, randomized clinical trial in elderly patients (over 80 years old) with unstable angina pectoris or Non-ST elevation myocardial infarction (NSTEMI). A total of 200 patients will be randomized to medical treatment (100 patients) or coronary angiography with revascularization if feasible (100 patients). Information regarding prior history, frailty, clinical presentation, in-hospital events, complications, angina, quality of life and mortality will be collected. Follow up time is 1 year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Aug 2009
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 7, 2014
CompletedFirst Posted
Study publicly available on registry
April 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2016
CompletedApril 29, 2014
January 1, 2014
5.4 years
January 7, 2014
April 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with major adverse cardiac and cerebral events (the composite of death, myocardial infarction, urgent revascularisation, recurrent hospitalization due to cardiac reason and stroke).
1 year
Secondary Outcomes (7)
Number of participants with major bleeding
1 month
Number of participants with major adverse cardiac or cerebral event
1 month
Number of participants with minor bleeding
1 month
Number of participants with composite of cardiac death or myocardial infarction
1 year
Change from baseline of participants level of quality of life measured with the SF-36 questionnaire at 12 months
1 year
- +2 more secondary outcomes
Study Arms (2)
Conservative therapy
NO INTERVENTIONOptimized medical therapy
Invasive therapy
EXPERIMENTALCoronary angiography and revascularization if feasible
Interventions
Coronary angiography and revascularization with PCI or CABG (coronary artery bypass grafting) if feasible
Eligibility Criteria
You may qualify if:
- \>80 years of age
- Acute coronary syndrome with ischemic symptoms (mainly chest pain) lasting over 10 minutes during the last 72 hours.
- AND at least one of the following:
- ST-segment depression on ECG \> 1mm
- Elevated cardiac troponins
- Written informed consent before randomization
You may not qualify if:
- Percutaneous coronary intervention (PCI) within 30 days prior to randomization
- Suspected ongoing active internal bleeding
- ST segment elevation of \>1mm in two contiguous leads on ECG
- Enrollment in another study that has not completed the follow up phase.
- Known allergy to aspirin or clopidogrel
- Severe dementia
- Expected limited 1 year survival due to other disease(s)
- Unwillingness to participate in the trial or expected problems with compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
Related Publications (2)
Hirlekar G, Libungan B, Karlsson T, Back M, Herlitz J, Albertsson P. Percutaneous coronary intervention in the very elderly with NSTE-ACS: the randomized 80+ study. Scand Cardiovasc J. 2020 Oct;54(5):315-321. doi: 10.1080/14017431.2020.1781243. Epub 2020 Jun 26.
PMID: 32586153DERIVEDLibungan B, Hirlekar G, Albertsson P. Coronary angioplasty in octogenarians with emergent coronary syndromes: study protocol for a randomized controlled trial. Trials. 2014 Sep 4;15:349. doi: 10.1186/1745-6215-15-349.
PMID: 25189626DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Per A Albertsson, PhD
Sahlgrenska University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Cardiology
Study Record Dates
First Submitted
January 7, 2014
First Posted
April 29, 2014
Study Start
August 1, 2009
Primary Completion
January 1, 2015
Study Completion
January 1, 2016
Last Updated
April 29, 2014
Record last verified: 2014-01